Abbott (ABT) SVP Eric Shroff logs share sale and tax disposition
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Abbott Laboratories senior vice president Eric Shroff reported two stock transactions involving Abbott common shares. On March 2, 2026, he completed an open-market sale of 709 shares at a price of $115.58 per share, leaving him with 39,164 directly held shares afterward.
On February 27, 2026, he disposed of 1,384 shares at $116.26 per share to cover tax withholding obligations, a non-market transaction typically linked to equity compensation. Both holdings are reported as direct ownership of common shares without par value.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 709 shares ($81,946)
Net Sell
2 txns
Insider
Shroff Eric
Role
Senior Vice President
Sold
709 shs ($82K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common shares without par value | 709 | $115.58 | $82K |
| Tax Withholding | Common shares without par value | 1,384 | $116.26 | $161K |
Holdings After Transaction:
Common shares without par value — 39,164 shares (Direct)
Footnotes (1)
FAQ
What insider transactions did Abbott Laboratories (ABT) report for Eric Shroff?
Abbott Laboratories senior vice president Eric Shroff reported an open-market sale of 709 common shares and a separate 1,384-share tax-withholding disposition. Both transactions involved directly held Abbott common shares without par value at prices slightly above $115 per share.
Are Eric Shroff’s Abbott (ABT) transactions classified as buys or sales?
The Form 4 shows a mix of sales-related activity. One transaction is an open-market sale of 709 shares coded as “S,” while the other is a 1,384-share tax-withholding disposition coded “F,” used to cover tax liabilities with shares rather than a traditional market sale.